Kayne Anderson Rudnick Investment Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$566 Buy
+23
New +$532 ﹤0.01% 927
2025
Q3
Sell
-136
Closed -$2.28K 1037
2025
Q2
$1.95K Buy
+136
New +$1.59K ﹤0.01% 849
2024
Q1
Sell
-4
Closed -$60 967
2023
Q4
$60 Hold
4
﹤0.01% 949
2023
Q3
$45 Hold
4
﹤0.01% 874
2023
Q2
$40 Sell
4
-150
-97% -$1.39K ﹤0.01% 872
2023
Q1
$1.45K Sell
154
-88
-36% -$1.04K ﹤0.01% 639
2022
Q4
$2.96K Sell
242
-3,667
-94% -$45.7K ﹤0.01% 631
2022
Q3
$49K Sell
3,909
-10,259,251
-100% -$179M ﹤0.01% 480
2022
Q2
$201M Sell
10,263,160
-1,984,958
-16% -$47M 0.64% 60
2022
Q1
$320M Buy
12,248,118
+905,307
+8% +$24.1M 0.85% 42
2021
Q4
$322M Sell
11,342,811
-121,040
-1% -$3.76M 0.74% 50
2021
Q3
$366M Buy
11,463,851
+513,789
+5% +$17.2M 0.89% 41
2021
Q2
$380M Buy
10,950,062
+1,636,811
+18% +$54M 0.94% 36
2021
Q1
$274M Buy
9,313,251
+1,078,211
+13% +$33.2M 0.74% 52
2020
Q4
$253M Buy
8,235,040
+2,535,699
+44% +$77.4M 0.73% 49
2020
Q3
$159M Buy
5,699,341
+1,204,266
+27% +$30.5M 0.58% 62
2020
Q2
$96.1M Buy
4,495,075
+910,087
+25% +$20.1M 0.4% 70
2020
Q1
$80.3M Buy
3,584,988
+760,580
+27% +$20.8M 0.46% 66
2019
Q4
$83.2M Buy
2,824,408
+141,875
+5% +$3.86M 0.4% 73
2019
Q3
$71.3M Buy
2,682,533
+152,131
+6% +$4.56M 0.37% 73
2019
Q2
$85.5M Buy
2,530,402
+265,051
+12% +$8.61M 0.45% 57
2019
Q1
$72.6M Buy
2,265,351
+451,963
+25% +$13.9M 0.41% 67
2018
Q4
$57.2M Buy
1,813,388
+137,270
+8% +$4.49M 0.39% 72
2018
Q3
$58.5M Buy
+1,676,118
New +$58.9M 0.34% 79

Other funds holding ELAN

Kayne Anderson Rudnick Investment Management's ELAN Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management opened a new position in Elanco Animal Health (ELAN) in Q2 2026: 23 shares worth $566. The stake represents ﹤0.01% of the portfolio and ranks #927 among its holdings. This is a return to the name: Kayne Anderson Rudnick Investment Management previously reported a position in ELAN as recently as Q2 2025.

Kayne Anderson Rudnick Investment Management first reported a position in ELAN in Q3 2018 and has held it in 24 quarters since. The position peaked at $380M in Q2 2021. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 23 shares of Elanco Animal Health worth $566 as of Q2 2026.
  • Elanco Animal Health was a new Kayne Anderson Rudnick Investment Management position in Q2 2026.
  • Elanco Animal Health made up ﹤0.01% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #927 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Elanco Animal Health in Q3 2018 and has held it in 24 quarters since.
  • Kayne Anderson Rudnick Investment Management's Elanco Animal Health position peaked at $380M in Q2 2021.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.